One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)

Omega-3 (n-3) treatment may lower cardiovascular risk, yet its effects on the circulating lipidome and relation to cardiovascular risk biomarkers are unclear. We hypothesized that n-3 treatment is associated with favorable changes in downstream fatty acids (FAs), oxylipins, bioactive lipids, clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Demler, Olga V., Liu, Yanyan, Luttmann-Gibson, Heike, Watrous, Jeramie D., Lagerborg, Kim A., Dashti, Hesam, Giulianini, Franco, Heath, Mallory, Camargo, Carlos A., Harris, William S., Wohlgemuth, Jay G., Andres, Allen M., Tivari, Saumya, Long, Tao, Najhawan, Mahan, Dao, Khoi, Prentice, James G., Larsen, Julia A., Okereke, Olivia I., Costenbader, Karen H., Buring, Julie E., Manson, JoAnn E., Cheng, Susan, Jain, Mohit, Mora, Samia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693376/
https://www.ncbi.nlm.nih.gov/pubmed/33120862
http://dx.doi.org/10.3390/metabo10110431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693376/
https://www.ncbi.nlm.nih.gov/pubmed/33120862
http://dx.doi.org/10.3390/metabo10110431

Ejemplares similares